Report Finds That Competition Created by Biosimilars Delivered $9.8 Billion in Savings Over the Past Five Years to the U.S. Healthcare System, Generating Savings for Patients, Payers and EmployersWith Both a Strong Innovator Portfolio and a Deep Investment in...
PROVIDENCE, RI & CAMBRIDGE, MA. Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for potential treatment of CNS diseases such as Alzheimer’s disease, today announced receiving a $500,000 Phase I...
KINGSTON, R.I. — September 1, 2021 — The federally funded Advance Clinical and Translational Research program — of which the University of Rhode Island is a key partner — recently received a $19.9 million grant from the National Institute of General Medical Sciences...
Patrick AndersonThe Providence Journal https://www.providencejournal.com/story/news/politics/2021/05/06/economist-tells-mckee-expect-growth-we-havent-seen-generation/4977368001/ The chief strategist at investment firm The Blackstone Group is bullish on the year ahead...
MAY 5, 2021 – PROVIDENCE, RI – RI Bio, the trade organization and voice of the Rhode Island Life Sciences industry, has formally launched a 501(c)3 Foundation arm to further support their mission. “Our nonprofit foundation will concentrate on fundraising and enabling...
Providence, RI – May 5th, 2021 – Lenoss Medical, a biomedical start up focused on physiological repair of osteoporotic spinal fractures has raised $1.3 million in a seed funding round from Cherrystone Angel Group, Slater Technology Fund, Walnut Ventures, Beacon...
Recent Comments